El Miedany, Yasser http://orcid.org/0000-0002-4543-692X
Abu-Zaid, Mohammed Hassan http://orcid.org/0000-0001-8436-8598
El Gaafary, Maha http://orcid.org/0000-0002-3948-3826
Mansour, Mona
Fathy, Nihal
Hassan, Waleed http://orcid.org/0000-0002-3238-6804
Mortada, Mohamed http://orcid.org/0000-0002-7198-9878
Eissa, Mervat http://orcid.org/0000-0001-7999-3401
Tabra, Samar Abdelhamed http://orcid.org/0000-0001-6414-5602
Galal, Salwa http://orcid.org/0000-0002-5010-2959
Foad, Nermeen http://orcid.org/0000-0002-6461-4939
Ibrahim, Rehab Ali http://orcid.org/0000-0003-3741-9940
Medhat, Basma http://orcid.org/0000-0001-6944-6367
El Olemy, Gehan http://orcid.org/0000-0001-5196-8300
Adel, Yasmin http://orcid.org/0000-0002-2798-2353
Ghaleb, Rasha http://orcid.org/0000-0003-4283-9034
Saber, Sally http://orcid.org/0000-0001-8162-4699
GadAllah, Naglaa
Article History
Received: 18 July 2022
Accepted: 6 September 2022
First Online: 10 October 2022
Declarations
:
: This study was performed in accordance with the Helsinki Declaration. This was a multistep process which followed the ‘Clinical, Evidence-based, Guidelines’ (CEG) initiative protocol (ethical approval code: 34842/8/21, ethical board Tanta University) aiming at setting up an actionable clinical gold standard for treat-to-target management of rheumatic and bone diseases.
: Not applicable
: The authors declare that Mona Mansour is editor in chief. Mohammed Hassan Abu-Zaid, Salwa Galal, and Rehab Ali are associate editors in the Egyptian Rheumatology and Rehabilitation. Mohammed Mortada, Yasser El Miedany, Naglaa Gadallah, and Waleed Hassan are from editorial board of the journal. The other authors declare that they have no competing interests.